Genius Group Limited(GNS)Earnings, Financials & Key RatiosGenius Group Limited (GNS) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2025Q2
the company's inability to generate positive cash flow, evidenced by a -5.2% FCF margin in 2025Q2, combined with a precarious $2.7M cash balance, presents significant solvency risks.
Genius Group Limited (GNS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Recent stock market news and headlines for Genius Group Limited (GNS)
John Jumper and Noam Shazeer, two of Google's top AI talents, left for new employers in June. Alphabet is still a strong business without them.
Investigational drug GNS561 showed a favorable safety and tolerability profile in a Phase 1b study evaluating its potential in combination with a MEK inhibitor (MEKi) Study conducted in a heavily pretreated, high-unmet-need population of KRAS-mutated cholangiocarcinoma (CCA) patients who had progressed after one or two failed lines of prior standard-of-care therapy Phase 2 initiation on track for initiation in 2H26 Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), June 23, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced positive Phase 1b results for GNS561 in combination therapy in patients with heavily pretreated cholangiocarcinoma, demonstrating a favorable safety and tolerability profile and early signs of antitumor activity. Clinical trial context and objective CCA is a rare and aggressive bile duct cancer, often diagnosed at an advanced stage.
32.6 million shares removed from Company's issued share capital in last 8 days, equivalent to 27% of the Company's public float. SINGAPORE, June 22, 2026 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) ("Genius Group", "GNS" or the "Company"), a leading AI-powered education group, today announced that it has bought back 6,037,851 Class A Ordinary Shares in a privately negotiated off-market transaction with a non-affiliated private holder, which together with the 6.6 million shares buyback announced on June 15, 2026 represents 96% of the 13.2 million share buyback authorised by the Company's Board of Directors on June 7, 2026.
Brings This Week's Total Reduction in Issued Capital to 26.6 Million Shares, Equivalent to Approximately 22% of Public Float. SINGAPORE, June 17, 2026 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) ("Genius Group", "GNS" or the "Company"), a leading AI-powered education group, today announced that it has returned and cancelled 20,000,000 Class A Ordinary Shares in relation to shares issued under the Company's Asset Purchase Agreement with Entrepreneur Resorts Ltd (“ERL”).
Key metrics vs top competitors for Genius Group Limited (GNS)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.20 | $16.14M | -0.37 | 6% | -658.94% | -62.79% | — | |
| $33.33 | $2.09B | 13.77 | 24.2% | 19.91% | 17.21% | — | |
| $78.85 | $1.79B | 14.55 | 3.96% | 10.21% | 7.85% | — | |
| $37.12 | $5.3B | 19.64 | 8.64% | 16.08% | 25.36% | — | |
| $145.26 | $3.94B | 18.84 | 7.07% | 26.92% | 29.53% | — | |
| $5.74 | $971.86M | -18.52 | 9.04% | -8.23% | -10.06% | — |
Genius Group Limited (GNS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when GNS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Genius Group Limited (GNS) stock FAQ — growth, dividends, profitability & financials explained
Genius Group Limited (GNS) reported $5.7M in revenue for fiscal year 2025. This represents a 37% decrease from $9.1M in 2018.
Genius Group Limited (GNS) grew revenue by 6.0% over the past year. This is steady growth.
Genius Group Limited (GNS) reported a net loss of $34.6M for fiscal year 2025.
Genius Group Limited (GNS) has a return on equity (ROE) of -62.8%. Negative ROE indicates the company is unprofitable.
Genius Group Limited (GNS) had negative free cash flow of $51.5M in fiscal year 2025, likely due to heavy capital investments.
